Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRemoved the topic 'Melanoma' and the related topic 'MedlinePlus Genetics' from the study page's taxonomy/related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics). Updated the page revision from v3.3.1 to v3.3.2.SummaryDifference0.2%

- Check22 days agoChange DetectedRevision: v3.3.1 was added; Melanoma and the related topic MedlinePlus Genetics, as well as Revision: v3.2.0, were removed.SummaryDifference0.2%

- Check29 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics) to the page's topics; removed the government funding status notice.SummaryDifference0.6%

- Check36 days agoChange DetectedRemoved Melanoma and related topics MedlinePlus Genetics from the page.SummaryDifference0.2%

- Check43 days agoChange DetectedMelanoma is now listed under MedlinePlus Genetics related topics on the page. The related topics section has been updated to include this item. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.